Published in Drug Law Weekly, May 13th, 2008
"At the 10-month follow-up examination, involution of the vasoproliferative tumor was seen with improvement of best-corrected visual acuity to 20/80. Photodynamic therapy is an effective treatment option in cases of exudative vasoproliferative tumors," wrote M.J. Saldanha and colleagues.
The researchers concluded: "Great variability exists in the parameters used to treat...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.